• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜异位症与卵巢癌风险:一种表观遗传联系

Endometriosis and ovarian cancer risk, an epigenetic connection.

作者信息

Brunty Sarah, Mitchell Brenda, Bou-Zgheib Nadim, Santanam Nalini

机构信息

Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA.

Department of Obstetrics and Gynecology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA.

出版信息

Ann Transl Med. 2020 Dec;8(24):1715. doi: 10.21037/atm-20-2449.

DOI:10.21037/atm-20-2449
PMID:33490227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812227/
Abstract

Endometriosis is a gynecological disorder that affects 176 million women worldwide and 1 in 10 females in the United States. Endometriosis most often affects women of child-bearing age, with most going undiagnosed. Endometriosis also shares many characteristics common to invasive cancer and has been known to be associated with epithelial ovarian cancer. Ovarian cancer is the 11 most common cancer among women and over 22,000 new cases will be diagnosed within the next year. Women most commonly diagnosed with this cancer are between the ages of 55-64 years, outside the range of the age of women affected with endometriosis. While no known cause of either disease has been established, epigenetic regulation is thought to play a major role in both. This review focuses on epigenetic changes that occur within each individual disease as well as those that are similar in both, suggesting a possible etiological link between the two diseases.

摘要

子宫内膜异位症是一种妇科疾病,全球有1.76亿女性受其影响,在美国每10名女性中就有1人患病。子宫内膜异位症最常影响育龄女性,大多数患者未被诊断出来。子宫内膜异位症还具有许多与侵袭性癌症相同的特征,并且已知与上皮性卵巢癌有关。卵巢癌是女性中第11常见的癌症,明年将有超过22000例新病例被诊断出来。最常被诊断出患有这种癌症的女性年龄在55至64岁之间,不在受子宫内膜异位症影响的女性年龄范围内。虽然这两种疾病的病因都尚未明确,但表观遗传调控被认为在两者中都起主要作用。本综述重点关注每种疾病中发生的表观遗传变化以及两者中相似的变化,提示这两种疾病之间可能存在病因学联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/c1675fc8148a/atm-08-24-1715-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/bbf907141eb6/atm-08-24-1715-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/05ff438a8d01/atm-08-24-1715-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/90a8b8fc4826/atm-08-24-1715-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/c1675fc8148a/atm-08-24-1715-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/bbf907141eb6/atm-08-24-1715-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/05ff438a8d01/atm-08-24-1715-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/90a8b8fc4826/atm-08-24-1715-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/7812227/c1675fc8148a/atm-08-24-1715-f4.jpg

相似文献

1
Endometriosis and ovarian cancer risk, an epigenetic connection.子宫内膜异位症与卵巢癌风险:一种表观遗传联系
Ann Transl Med. 2020 Dec;8(24):1715. doi: 10.21037/atm-20-2449.
2
Endometriosis and ovarian cancer.子宫内膜异位症与卵巢癌。
World J Clin Oncol. 2014 Dec 10;5(5):800-5. doi: 10.5306/wjco.v5.i5.800.
3
ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer.ARID1a 基因作为一种潜在的早期标志物来应对与子宫内膜异位症相关的卵巢癌。
Aging Dis. 2023 Nov 17;15(6):2331-2333. doi: 10.14336/AD.2023.1109.
4
Role of microRNAs in gynecological pathology.微小 RNA 在妇科病理学中的作用。
Curr Med Chem. 2012;19(15):2406-13. doi: 10.2174/092986712800269362.
5
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
6
Endometriosis-associated ovarian cancer: What have we learned so far?内异症相关卵巢癌:我们迄今了解多少?
Clin Chim Acta. 2019 Jun;493:63-72. doi: 10.1016/j.cca.2019.02.016. Epub 2019 Feb 15.
7
Cancer Implications for Patients with Endometriosis.子宫内膜异位症患者的癌症影响
Semin Reprod Med. 2017 Jan;35(1):110-116. doi: 10.1055/s-0036-1597120. Epub 2017 Jan 3.
8
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.有或无子宫内膜异位症女性的口服避孕药使用情况、生殖史与上皮性卵巢癌风险
Am J Obstet Gynecol. 2004 Sep;191(3):733-40. doi: 10.1016/j.ajog.2004.03.035.
9
A Nationwide Cohort Study on the risk of non-gynecological cancers in women with surgically verified endometriosis.一项全国性队列研究:手术确诊的子宫内膜异位症女性的非妇科癌症风险。
Int J Cancer. 2018 Dec 1;143(11):2725-2731. doi: 10.1002/ijc.31721. Epub 2018 Sep 26.
10
Association between endometriosis and gynecological cancers: a critical review of the literature.子宫内膜异位症与妇科癌症的关联:文献综述的批判性评价。
Arch Gynecol Obstet. 2020 Feb;301(2):355-367. doi: 10.1007/s00404-020-05445-1. Epub 2020 Feb 5.

引用本文的文献

1
Endometriosis and Ovarian Cancer: Insights from NHANES and Mendelian Randomization Analysis.子宫内膜异位症与卵巢癌:来自美国国家健康与营养检查调查(NHANES)及孟德尔随机化分析的见解
Reprod Sci. 2025 Jun 23. doi: 10.1007/s43032-025-01910-x.
2
Advances in research on malignant transformation of endometriosis-associated ovarian cancer.子宫内膜异位症相关卵巢癌恶性转化的研究进展
Front Oncol. 2024 Oct 9;14:1475231. doi: 10.3389/fonc.2024.1475231. eCollection 2024.
3
Research progress in endometriosis-associated ovarian cancer.子宫内膜异位症相关卵巢癌的研究进展

本文引用的文献

1
microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis.微小RNA-141通过抑制子宫内膜异位症中TGF-β1/SMAD2信号通路来抑制TGF-β1诱导的上皮-间质转化。
Arch Gynecol Obstet. 2020 Mar;301(3):707-714. doi: 10.1007/s00404-019-05429-w. Epub 2020 Jan 4.
2
Evaluation of miR-135a/b expression in endometriosis lesions.子宫内膜异位症病灶中miR-135a/b表达的评估。
Biomed Rep. 2019 Oct;11(4):181-187. doi: 10.3892/br.2019.1237. Epub 2019 Sep 2.
3
Effects of lncRNA BANCR on endometriosis through ERK/MAPK pathway.
Front Oncol. 2024 Apr 25;14:1381244. doi: 10.3389/fonc.2024.1381244. eCollection 2024.
4
Curcumol Attenuates Endometriosis by Inhibiting the JAK2/STAT3 Signaling Pathway.姜黄素通过抑制 JAK2/STAT3 信号通路减轻子宫内膜异位症。
Med Sci Monit. 2022 Mar 13;28:e934914. doi: 10.12659/MSM.934914.
5
Downregulated ADARB1 Facilitates Cell Proliferation, Invasion and has Effect on the Immune Regulation in Ovarian Cancer.ADARB1表达下调促进卵巢癌细胞增殖、侵袭并影响免疫调节。
Front Bioeng Biotechnol. 2021 Dec 23;9:792911. doi: 10.3389/fbioe.2021.792911. eCollection 2021.
6
Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma.TEAD家族在卵巢浆液性癌诊断、预后及免疫反应中的意义
Int J Gen Med. 2021 Oct 27;14:7133-7143. doi: 10.2147/IJGM.S336602. eCollection 2021.
7
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis.子宫内膜异位症中 EZH2-miR-155 交叉对话的腹膜调节剂。
Int J Mol Sci. 2021 Mar 28;22(7):3492. doi: 10.3390/ijms22073492.
lncRNA BANCR 通过 ERK/MAPK 通路对子宫内膜异位症的影响。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6806-6812. doi: 10.26355/eurrev_201908_18719.
4
miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12.miR-141-3p 通过靶向 KLF-12 影响子宫内膜基质细胞的凋亡和迁移。
Pflugers Arch. 2019 Aug;471(8):1055-1063. doi: 10.1007/s00424-019-02283-2. Epub 2019 May 25.
5
Seven Hormonal Biomarkers for Diagnosing Endometriosis: Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy.七种用于诊断子宫内膜异位症的激素生物标志物:诊断试验准确性的荟萃分析和调整间接比较。
J Minim Invasive Gynecol. 2019 Sep-Oct;26(6):1026-1035.e4. doi: 10.1016/j.jmig.2019.04.004. Epub 2019 Apr 6.
6
Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.介导 PRC2 募集和 H3K27 甲基化的分子机制。
Mol Cell. 2019 Apr 4;74(1):8-18. doi: 10.1016/j.molcel.2019.03.011.
7
Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.了解子宫内膜异位症的恶性转化:与病理相关的影像学特征。
Abdom Radiol (NY). 2020 Jun;45(6):1762-1775. doi: 10.1007/s00261-019-01914-7.
8
Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.H3K79甲基转移酶Dot1L的缺失促进卵巢癌细胞侵袭和癌症干细胞样特性。
Am J Transl Res. 2019 Feb 15;11(2):1145-1153. eCollection 2019.
9
Endometriosis and nuclear receptors.子宫内膜异位症与核受体。
Hum Reprod Update. 2019 Jul 1;25(4):473-485. doi: 10.1093/humupd/dmz005.
10
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab.晚期卵巢癌女性的一线治疗:聚焦贝伐单抗。
Onco Targets Ther. 2019 Feb 8;12:1095-1103. doi: 10.2147/OTT.S155425. eCollection 2019.